Site updated at Wednesday, 22 June 2016

Living with Dementia


Groups convince FDA to ease Alzheimer’s trial rules

Academic and industry experts said on Tuesday they have convinced U.S. regulators to ease safety restrictions imposed on clinical trials of Alzheimer’s drugs, a move that could improve the chances that a drug being developed jointly by Pfizer and Johnson & Johnson might succeed.

A 2008 study of 240 patients testing that drug, known… Groups convince FDA to ease Alzheimer’s trial rules   

Alzheimer’s Disease

arteriosclerosis2 - exelon1 - cognitive functions1 - chronic sleep deprivation1 - synaptic loss1 - obstructive lung disease1 - ipscs1 - permanent brain damage1 - socioeconomic boundaries1 - dementia in elderly1 - signs of parkinson's1 - dementia sufferers1 - quality standards subcommittee1 - irritability1 - dat2 - huntingtons disease4 - alzheimer's researchers1 - alzheimer’s disease8 - cognitive deficits1 - interviews by magistrates1 - mentally weak1 - cerebral parenchyma1 - huntington's chorea1 - baroness thatcher1 - dysarthria1 - dementia of the alzheimer type1 - dementia alliance1 - vesanic dementia2 - stroke risk factors1 - sinus issues1 -